PubRank

C Szabó

Author PubWeight™ 157.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 2001 2.91
2 Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol 1996 2.55
3 Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J 2000 2.53
4 Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 1996 2.48
5 Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: I kappa B alpha degradation, induction of nitric oxide synthase, induction of proinflammatory mediators, and cardiovascular dysfunction. J Immunol 2001 2.44
6 Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J Immunol 1999 1.99
7 Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc Natl Acad Sci U S A 1993 1.96
8 Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ Res 1998 1.80
9 Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure. J Pharmacol Exp Ther 2002 1.69
10 Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity. Br J Pharmacol 1995 1.67
11 Poly (ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia. Shock 2000 1.64
12 Circulating methemoglobin and nitrite/nitrate concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock. Crit Care Med 1997 1.61
13 Inosine improves gut permeability and vascular reactivity in endotoxic shock. Crit Care Med 2001 1.57
14 Poly(ADP-ribose) synthetase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells. Gastroenterology 1998 1.54
15 Nitric oxide sensitivity of the aconitases. J Biol Chem 1997 1.51
16 Effects of a novel guanylyl cyclase inhibitor on the vascular actions of nitric oxide and peroxynitrite in immunostimulated smooth muscle cells and in endotoxic shock. Crit Care Med 1999 1.49
17 Peroxynitrite-mediated DNA strand breakage activates poly-adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J Immunol 1996 1.48
18 Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J Thromb Haemost 2004 1.48
19 Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock. J Immunol 2000 1.47
20 Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. Diabetologia 2007 1.46
21 Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation 2000 1.46
22 Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br J Pharmacol 1993 1.40
23 Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circ Res 2001 1.39
24 Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly (ADP-ribose) synthetase (PARS) activation. Immunology 1998 1.34
25 An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice. Eur J Pharmacol 1998 1.29
26 Biology of nitric oxide signaling. Crit Care Med 2000 1.25
27 Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Int J Mol Med 2001 1.24
28 Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflamm Res 2001 1.22
29 Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase. Gut 1999 1.19
30 Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. J Immunol 1998 1.18
31 Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat. Br J Pharmacol 1998 1.18
32 Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system. Biochem Pharmacol 1998 1.17
33 Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. Cardiovasc Res 1997 1.17
34 Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 1995 1.16
35 Blockade of Poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis. Gastroenterology 1999 1.15
36 The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol 1997 1.14
37 Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkappaB activation. FASEB J 1998 1.14
38 Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. Gastroenterology 1998 1.13
39 Antiinflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Radic Biol Med 1998 1.12
40 Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharmacol 1997 1.10
41 Antiperoxynitrite strategies for the experimental therapy of shock. Crit Care Med 2000 1.10
42 Lipocortin 1 protects against splanchnic artery occlusion and reperfusion injury by affecting neutrophil migration. J Immunol 1997 1.09
43 Proinflammatory cytokines depress cardiac efficiency by a nitric oxide-dependent mechanism. Am J Physiol 1998 1.09
44 Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet beta-cells. Diabetes 1997 1.08
45 Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation. J Mol Med (Berl) 2001 1.08
46 Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy. Diabetologia 2004 1.08
47 Effects of NG-nitro-L-arginine and L-arginine on regional cerebral blood flow in the cat. J Physiol 1992 1.07
48 Protective effect of melatonin in carrageenan-induced models of local inflammation: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. J Pineal Res 1997 1.07
49 An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice. J Autoimmun 2001 1.06
50 Inosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture. Am J Respir Crit Care Med 2001 1.05
51 Bacterial invasion is not required for activation of NF-kappaB in enterocytes. Infect Immun 1999 1.03
52 Effect of genetic disruption of poly (ADP-ribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury. Shock 2000 1.03
53 Effect of L-buthionine-(S,R)-sulphoximine, an inhibitor of gamma-glutamylcysteine synthetase on peroxynitrite- and endotoxic shock-induced vascular failure. Br J Pharmacol 1998 1.03
54 NFkappaB1 (p50)-deficient mice are not susceptible to multiple low-dose streptozotocin-induced diabetes. J Endocrinol 2002 1.02
55 Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Br J Pharmacol 1995 1.02
56 Protection by inhibition of poly (ADP-ribose) synthetase against oxidant injury in cardiac myoblasts In vitro. J Mol Cell Cardiol 1997 1.01
57 Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. Am J Physiol 1996 1.00
58 The crucial role of IL-10 in the suppression of the immunological response in mice exposed to staphylococcal enterotoxin B. Eur J Immunol 1998 1.00
59 Pathophysiologic role of oxidative stress-induced poly(ADP-ribose) polymerase-1 activation: focus on cell death and transcriptional regulation. Cell Mol Life Sci 2005 0.99
60 Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death. FASEB J 2001 0.98
61 Transcriptional regulation of human inducible nitric oxide synthase gene in an intestinal epithelial cell line. Am J Physiol 1997 0.97
62 Nicotine reduces the incidence of type I diabetes in mice. J Pharmacol Exp Ther 2002 0.97
63 Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase. Mol Med 2001 0.97
64 Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences. Br J Pharmacol 2001 0.96
65 Role of peroxynitrite and neuronal nitric oxide synthase in the activation of poly(ADP-ribose) synthetase in a murine model of cerebral ischemia-reperfusion. Neurosci Lett 1998 0.96
66 ATP suppression of interleukin-12 and tumour necrosis factor-alpha release from macrophages. Br J Pharmacol 2000 0.96
67 Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 1997 0.96
68 Melatonin is a scavenger of peroxynitrite. Life Sci 1997 0.96
69 Role of inducible nitric oxide synthase in the regulation of neutrophil migration in zymosan-induced inflammation. Immunology 1998 0.96
70 Spermine differentially regulates the production of interleukin-12 p40 and interleukin-10 and suppresses the release of the T helper 1 cytokine interferon-gamma. Shock 2000 0.95
71 K(ATP)-channel inhibition improves hemodynamics and cellular energetics in hemorrhagic shock. Am J Physiol 1997 0.95
72 Collagen induced arthritis: reversal by mercaptoethylguanidine, a novel antiinflammatory agent with a combined mechanism of action. J Rheumatol 1998 0.95
73 Peroxynitrite is a mediator of cytokine-induced destruction of human pancreatic islet beta cells. Lab Invest 2001 0.94
74 Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice. J Neuroimmunol 1998 0.94
75 Activation of soluble guanylyl cyclase by a factor other than nitric oxide or carbon monoxide contributes to the vascular hyporeactivity to vasoconstrictor agents in the aorta of rats treated with endotoxin. Biochem Biophys Res Commun 1994 0.93
76 The effect of inducible nitric oxide synthase (iNOS) inhibition on smoke inhalation injury in sheep. Shock 2000 0.93
77 Peroxynitrite production and activation of poly (adenosine diphosphate-ribose) synthetase in spinal cord injury. Ann Neurol 1999 0.93
78 Protein kinase C-dependent activation of NF-kappaB in enterocytes is independent of IkappaB degradation. Gastroenterology 1999 0.93
79 Isoproterenol inhibits Il-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages. Brain Res Bull 1998 0.93
80 Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform. Br J Pharmacol 1996 0.91
81 Nitric oxide and shock. Dis Mon 1997 0.91
82 IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses. Br J Pharmacol 1999 0.91
83 Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice. Br J Pharmacol 2006 0.91
84 Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes. Br J Pharmacol 2001 0.90
85 Anti-inflammatory effects of inosine in human monocytes, neutrophils and epithelial cells in vitro. Int J Mol Med 2001 0.90
86 Exogenous and endogenous catecholamines inhibit the production of macrophage inflammatory protein (MIP) 1 alpha via a beta adrenoceptor mediated mechanism. Br J Pharmacol 1998 0.90
87 Mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J Pharmacol Exp Ther 1998 0.90
88 Amelioration by mercaptoethylguanidine of the vascular and energetic failure in haemorrhagic shock in the anesthetised rat. Eur J Pharmacol 1997 0.89
89 Importance of basal nitric oxide synthesis in regulation of myocardial blood flow. Cardiovasc Res 1991 0.89
90 Peroxynitrite production, DNA breakage, and poly(ADP-ribose) polymerase activation in a mouse model of oxazolone-induced contact hypersensitivity. J Invest Dermatol 2001 0.89
91 Regulation of macrophage inflammatory protein-1 alpha expression and function by endogenous interleukin-10 in a model of acute inflammation. Biochem Biophys Res Commun 1999 0.88
92 The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity. Br J Pharmacol 1997 0.88
93 Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts. J Mol Cell Cardiol 1999 0.88
94 Evidence for reactive nitrogen species formation in the gingivomucosal tissue. J Dent Res 2001 0.87
95 Application of an anti-HQIgY antibody for the measurement of IgY concentrations of hen's and quail's serum and yolk. Acta Physiol Hung 1999 0.86
96 Requirement of intracellular calcium mobilization for peroxynitrite-induced poly(ADP-ribose) synthetase activation and cytotoxicity. Mol Pharmacol 1999 0.86
97 Sulphasalazine inhibits macrophage activation: inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expression. Immunology 2001 0.86
98 Modulation of peroxynitrite- and hypochlorous acid-induced inactivation of alpha1-antiproteinase by mercaptoethylguanidine. Br J Pharmacol 1999 0.86
99 3-Aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, improves hemodynamics and prolongs survival in a porcine model of hemorrhagic shock. Shock 1998 0.86
100 Oxidation, tyrosine nitration and cytostasis induction in the absence of inducible nitric oxide synthase. Int J Mol Med 1998 0.86
101 Decreased pulmonary compliance is an early indicator of pulmonary oxygen injury. J Surg Res 1997 0.86
102 Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in a carrageenan-induced model of local inflammation. Eur J Pharmacol 1998 0.86
103 Low-level expression and limited role for the inducible isoform of nitric oxide synthase in the vascular hyporeactivity and mortality associated with cecal ligation and puncture in the rat. Shock 1996 0.85
104 Suppression of IL-12 production by phosphodiesterase inhibition in murine endotoxemia is IL-10 independent. Eur J Immunol 1998 0.85
105 Inhibition of poly(ADP-ribose) synthetase (PARS) and protection against peroxynitrite-induced cytotoxicity by zinc chelation. Br J Pharmacol 1999 0.85
106 Partial protection by poly(ADP-ribose) polymerase inhibitors from nitroxyl-induced cytotoxity in thymocytes. Free Radic Biol Med 2001 0.85
107 Role of peroxynitrite in the protein oxidation and apoptotic DNA fragmentation in vascular smooth muscle cells stimulated with bacterial lipopolysaccharide and interferon-gamma. Shock 1997 0.85
108 Role of poly(ADP-ribose) synthetase activation in the development of experimental allergic encephalomyelitis. J Neuroimmunol 2001 0.85
109 Role of the activation of the nuclear enzyme poly(ADP-ribose) polymerase in the pathogenesis of periodontitis. J Dent Res 2003 0.84
110 Selective inhibition of the inducible isoform of nitric oxide synthase prevents pulmonary transvascular flux during acute endotoxemia. J Pediatr Surg 1996 0.84
111 Ursodeoxycholate inhibits induction of NOS in human intestinal epithelial cells and in vivo. Am J Physiol 1997 0.84
112 Adenovirus infection increases iNOS and peroxynitrite production in the lung. Am J Physiol Lung Cell Mol Physiol 2001 0.83
113 Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production by dopamine receptor agonists and antagonists in mice. Immunol Lett 1996 0.83
114 Differential effects of hyperoxia on the inducible and constitutive isoforms of nitric oxide synthase in the lung. Shock 1997 0.83
115 Evidence for the expression of cyclooxygenase-2 enzyme in periodontitis. Life Sci 2001 0.82
116 Role of peroxynitrite and activation of poly (ADP-ribose) synthase in the vascular failure induced by zymosan-activated plasma. Br J Pharmacol 1997 0.82
117 Inhibition of the induction of nitric oxide synthase by spermine is modulated by aldehyde dehydrogenase. Biochem Biophys Res Commun 1994 0.82
118 S-nitrosoglutathione-containing hydrogel increases dermal blood flow in streptozotocin-induced diabetic rats. Br J Dermatol 2007 0.81
119 BCL-2 protects peroxynitrite-treated thymocytes from poly(ADP-ribose) synthase (PARS)-independent apoptotic but not from PARS-mediated necrotic cell death. Free Radic Biol Med 2000 0.81
120 Crucial role of apopain in the peroxynitrite-induced apoptotic DNA fragmentation. Free Radic Biol Med 1998 0.80
121 Calcium channel blockers and dantrolene differentially regulate the production of interleukin-12 and interferon-gamma in endotoxemic mice. Brain Res Bull 1998 0.80
122 Beneficial effects of mercaptoethylguanidine, an inhibitor of the inducible isoform of nitric oxide synthase and a scavenger of peroxynitrite, in a porcine model of delayed hemorrhagic shock. Crit Care Med 1999 0.79
123 Amidines are potent inhibitors of nitric oxide synthases: preferential inhibition of the inducible isoform. Eur J Pharmacol 1995 0.79
124 Intratracheal instillation of a novel NO/nucleophile adduct selectively reduces pulmonary hypertension. J Appl Physiol (1985) 1997 0.79
125 Poly (ADP-ribose) synthetase activation mediates pulmonary microvascular and intestinal mucosal dysfunction in endotoxin shock. Life Sci 1998 0.79
126 Modulation by dantrolene of endotoxin-induced interleukin-10, tumour necrosis factor-alpha and nitric oxide production in vivo and in vitro. Br J Pharmacol 1998 0.79
127 Interleukin-1 beta and interferon-gamma regulate interleukin-6 production in cultured human intestinal epithelial cells. Shock 1997 0.79
128 Protective effects of nicotinamide against nitric oxide-mediated delayed vascular failure in endotoxic shock: potential involvement of polyADP ribosyl synthetase. Shock 1996 0.78
129 Hypothalamic blood flow remains unaltered following chronic nitric oxide synthase blockade in rats. Neurosci Lett 1995 0.78
130 Effects of selective nitric oxide synthase inhibition in hyperdynamic endotoxemia in dogs. Eur Surg Res 1999 0.78
131 Effect of mercaptoethylguanidine scavengers of peroxynitrite on the development of experimental allergic encephalomyelitis in PLSJL mice. Neurosci Lett 2001 0.78
132 Protective effects of 5-iodo-6-amino-1,2-benzopyrone, an inhibitor of poly(ADP-ribose) synthetase against peroxynitrite-induced glial damage and stroke development. Eur J Pharmacol 1998 0.78
133 Lipid A and the lipid A analogue anti-tumour compound ONO-4007 induce nitric oxide synthase in vitro and in vivo. Eur J Pharmacol 1995 0.78
134 Effects of combined selective iNOS inhibition and peroxynitrite blockade during endotoxemia in pigs. Shock 2001 0.78
135 Differential vascular actions of ethanol in feline middle cerebral and mesenteric artery. Acta Physiol Hung 1991 0.77
136 Nitric oxide, intracellular calcium overload, and cytotoxicity. Shock 1996 0.77
137 IL-1beta induction of NF-kappaB activation in human intestinal epithelial cells is independent of oxyradical signaling. Shock 2000 0.77
138 Amrinone and theophylline differentially regulate cytokine and nitric oxide production in endotoxemic mice. Shock 1997 0.77
139 Contractile and endothelium-dependent dilatory responses of cerebral arteries at various extracellular magnesium concentrations. J Cereb Blood Flow Metab 1991 0.77
140 NADPH diaphorase histochemistry detects inducible nitric oxide synthetase activity in the thymus of naive and staphylococcal enterotoxin B-stimulated mice. J Histochem Cytochem 1998 0.77
141 Inhibition of the Na(+)/H(+) antiporter suppresses IL-12 p40 production by mouse macrophages. Biochim Biophys Acta 2001 0.77
142 Topical administration of a novel nitric oxide donor, linear polyethylenimine-nitric oxide/nucleophile adduct (DS1), selectively increases vaginal blood flow in anesthetized rats. Int J Impot Res 2003 0.77
143 Poly-ADP-ribose polymerase inhibition reduces mesenteric injury after cardiopulmonary bypass. Thorac Cardiovasc Surg 2004 0.76
144 Production of interleukin-12 is under the control of endogenous interleukin-10 in myocardial ischemia-reperfusion. Shock 2001 0.76
145 Effect of the phosphodiesterase III inhibitor amrinone on cytokine and nitric oxide production in immunostimulated J774.1 macrophages. Eur J Pharmacol 1997 0.76
146 Nitric oxide, perioxynitrite and poly(ADP-ribose) synthetase in anaphylactic shock. Shock 1997 0.75
147 Simultaneous targeting or multiple pathways of shock: how promising, how novel? Shock 1999 0.75
148 Mercaptoethylguanidine inhibits the inflammatory response in a murine model of chronic infection with Pseudomonas aeruginosa. J Pharmacol Exp Ther 2000 0.75
149 Methylene blue infusion in septic shock. Crit Care Med 1995 0.75
150 Inhaled nitric oxide in ARDS: is the question closed? Crit Care Med 1999 0.75
151 Effect of L-arginine on adrenal and renal blood flows during hemorrhage in cats. Kidney Int Suppl 1998 0.75
152 [Developing subcutaneous emphysema after dental care]. Fogorv Sz 1997 0.75
153 Role of platelet-activating factor in the development of endothelial dysfunction in hemorrhagic hypotension and retransfusion. Thromb Res 1992 0.75
154 Pole reversals and hypothalamic self-stimulation: ascending spread of rewarding excitation. Physiol Behav 1972 0.75
155 Effect of hemorrhagic hypotension on cerebrovascular reactivity and ultrastructure in the cat. Stroke 1991 0.75
156 [Surgery in the preparation for removable dentures--preprosthetic surgery]. Zahnarztl Prax 1967 0.75
157 [Maxillary fractures at the Stomatologic Clinic of Debrecen during 1940-1967]. Fogorv Sz 1968 0.75
158 [A new dental instrument]. Fogorv Sz 1966 0.75
159 [The tooth root in the maxillary sinus]. Bl Zahnheilkd 1969 0.75
160 [Bite injury of the tip of the tongue]. Zahnarztl Welt Zahnarztl Rundsch ZWR Zahnarztl Reform 1967 0.75
161 T-cell deficiency in Suffolk lambs. Acta Vet Hung 1993 0.75
162 Prevention of the hemorrhagic hypotension-induced hepatic arterial vasoconstriction by L-arginine and naloxone. Shock 1999 0.75
163 Inhibition of nitric oxide synthase with pyrazole-1-carboxamidine and related compounds. Biochem Pharmacol 1997 0.75
164 [Bite injury of the tongue]. Fogorv Sz 1967 0.75
165 Cytokines stimulate expression of inducible nitric oxide synthase in DLD-1 human adenocarcinoma cells by activating poly(A) polymerase. Inflamm Res 2004 0.75
166 [Results of compression osteosynthesis in the dog mandible]. Fogorv Sz 1967 0.75
167 [Granuloma gangrenescens]. Orv Hetil 1966 0.75
168 [Postoperative wound suppuration]. Orv Hetil 1971 0.75
169 Maturation-dependent sequential expression of interferon regulatory factor-1 and inducible nitric oxide synthase in cultured human enterocytes. Shock 2000 0.75
170 Prevention of early myocardial depression in hyperdynamic endotoxemia in dogs. Shock 2000 0.75
171 Effects of S-isopropyl isothiourea, a potent inhibitor of nitric oxide synthase, in severe hemorrhagic shock. J Appl Physiol (1985) 1996 0.75
172 Hydroxyguanidines inhibit peroxynitrite-induced oxidation. Free Radic Biol Med 1998 0.75
173 [The tooth root in the maxillary sinus]. Bl Zahnheilkd 1969 0.75
174 Effects of nitric oxide synthase inhibition on the hemodynamic changes in hyperdynamic endotoxemia. Acta Chir Hung 1997 0.75
175 Comparison of the inhibitory effect of isothiourea and mercapto-alkylguanidine derivatives on the alternative pathways of arginine metabolism in macrophages. Life Sci 1997 0.75
176 [Mandibular periostitis following tooth extraction from the maxilla]. Fogorv Sz 1970 0.75
177 [Granuloma gangraenescens]. Zahnarztl Welt Zahnarztl Rundsch ZWR Zahnarztl Reform 1965 0.75
178 [Mathematical model of intrusion of a tooth root into the maxillary sinus]. Orv Hetil 1970 0.75
179 [The role of nitric oxide synthase, and of granulocytes, in endotoxin-induced early myocardial depression]. Magy Seb 2000 0.75
180 Correlation of EEG asymmetry and hypnotic susceptibility. Acta Physiol Hung 1999 0.75
181 Intravenous beta-endorphin administration fails to alter hypothalamic blood flow in rats expressing normal or reduced nitric oxide synthase activity. Peptides 1996 0.75